Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Point Biopharma Global Inc. (PNT) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Point Biopharma Global Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1811764.
Total stock buying since 2022: $448,981.
Total stock sales since 2022: $217,895,083.
Total stock option exercises since 2022: $125,013.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 0 | $0 | 17,161,278 | $213,657,911 | 17,936 | $125,013 |
| 2022 | 70,830 | $448,981 | 564,204 | $4,237,172 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-12 | 0 | $0 | 17,161,278 | $213,657,911 | 0 | $0 |
| 2023-03 | 0 | $0 | 0 | $0 | 17,936 | $125,013 |
| 2022-11 | 70,830 | $448,981 | 0 | $0 | 0 | $0 |
| 2022-05 | 0 | $0 | 564,204 | $4,237,172 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-12-18 | Lampert Mark N | Sale | 17,161,278 | 12.45 | 213,657,911 |
| 2023-03-21 | Hogue Gerald L. | Option Ex | 17,936 | 6.97 | 125,013 |
| 2022-11-29 | Mccann Joe A. (Chief Executive Officer) | Buy | 2,160 | 6.64 | 14,342 |
| 2022-11-28 | Malik Rajesh | Buy | 3,700 | 6.66 | 24,642 |
| 2022-11-25 | Hogue Gerald L. | Buy | 3,660 | 6.82 | 24,942 |
| 2022-11-23 | Lubner David Charles | Buy | 3,600 | 6.85 | 24,660 |
| 2022-11-21 | Margolin Yael | Buy | 1,710 | 6.56 | 11,217 |
| 2022-11-18 | Goodman Jonathan R. | Buy | 6,000 | 6.33 | 37,980 |
| 2022-11-18 | Silber Allan C (Executive Chairman) | Buy | 22,397 | 6.50 | 145,580 |
| 2022-11-17 | Silber Allan C (Executive Chairman) | Buy | 27,603 | 6.00 | 165,618 |
| 2022-05-25 | Fleshner Neil E. (Chief Medical Officer) | Sale | 564,204 | 7.51 | 4,237,172 |
Insider trading activities including stock purchases, stock sales, and option exercises of PNT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Point Biopharma Global Inc. (symbol PNT, CIK number 1811764) see the Securities and Exchange Commission (SEC) website.